ProMIS Neurosciences Inc has a consensus price target of $5.67 based on the ratings of 3 analysts. The high is $8 issued by BTIG on October 3, 2023. The low is $3 issued by Maxim Group on May 12, 2025. The 3 most-recent analyst ratings were released by Maxim Group, Guggenheim, and BTIG on May 12, 2025, April 1, 2025, and October 3, 2023, respectively. With an average price target of $5.67 between Maxim Group, Guggenheim, and BTIG, there's an implied 1037.88% upside for ProMIS Neurosciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/12/2025 | Buy Now | 502.41% | Maxim Group | Jason McCarthy40% | → $3 | Initiates | → Buy | Get Alert |
04/01/2025 | Buy Now | 1104.82% | Guggenheim | Eddie Hickman50% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
02/26/2025 | Buy Now | — | Guggenheim | Eddie Hickman50% | — | Reiterates | Buy → Buy | Get Alert |
10/03/2023 | Buy Now | 1506.43% | BTIG | Thomas Shrader40% | → $8 | Initiates | → Buy | Get Alert |
The latest price target for ProMIS Neurosciences (NASDAQ:PMN) was reported by Maxim Group on May 12, 2025. The analyst firm set a price target for $3.00 expecting PMN to rise to within 12 months (a possible 502.41% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for ProMIS Neurosciences (NASDAQ:PMN) was provided by Maxim Group, and ProMIS Neurosciences initiated their buy rating.
There is no last upgrade for ProMIS Neurosciences
There is no last downgrade for ProMIS Neurosciences.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProMIS Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProMIS Neurosciences was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.
While ratings are subjective and will change, the latest ProMIS Neurosciences (PMN) rating was a initiated with a price target of $0.00 to $3.00. The current price ProMIS Neurosciences (PMN) is trading at is $0.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.